AOL Money & Finance

AMETEK posts

Feed

The week in preview: End-of-quarter expectations

Even if the national headlines weren't already providing enough focus on the economy, plenty of economic data is due out as the month and the quarter wind down. U.S. economic data scheduled to be released this week include:

Other economic events scheduled for this week include:

Continue reading The week in preview: End-of-quarter expectations

Earnings highlights: Microsoft, Yahoo!, Apple, Amazon, Texas Instruments and others

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Microsoft, Yahoo!, Apple, Amazon, Texas Instruments and others

AMETEK (AME): Shares defining bullish 'flag' pattern

AMETEK Inc. (NYSE: AME) manufactures and markets electronic instruments and electromechanical devices in North America, Europe, Asia and South America. The firm's Electronic Instruments Group makes testing, monitoring and calibration instruments for the aerospace, transportation, research, industrial and power markets. Its Electromechanical Group produces motors, blowers, fans, heat exchangers and connectors for appliance, defense, medical and computer applications. The group also makes industrial specialty metals. General Electric (NYSE: GE) and Agilent Technologies (NYSE: A) are major competitors.

The firm pleased investors last week, when it reported fiscal Q4 EPS of 57 cents and revenues of $583.3 million. Analysts had been looking for 53 cents and $553 million. Management also predicted FY08 EPS of $2.40-$2.45, versus Street consensus of $2.43. Friedman Billings subsequently boosted its rating on the shares to "outperform".

Continue reading AMETEK (AME): Shares defining bullish 'flag' pattern

Analyst initiations 8-29-07: A, DTV, NATI and OWW

MOST NOTEWORTHY: Orbitz Worldwide (OWW), Agilent (A), National Instruments (NATI) and Ametek (AME) were today's noteworthy initiations:
  • Orbitz Worldwide (NYSE: OWW) was initiated by a host of firms today:
    • Thomas Weisel and Morgan Stanley started Orbitz with an Overweight rating.
    • Pacific Crest and Piper Jaffray started shares with Overweight ratings, and $18 and $16 targets, respectively.
    • Stifel initiated Orbitz with a Buy rating and $16 target, while JP Morgan started shares with a Neutral rating.
  • Citigroup finds the valuation of Agilent (NYSE: A) attractive at current levels and started shares with a Buy rating, They expect a recovery in the company's Electronic Measurement business to drive shares to $43.
  • Citigroup initiated National Instruments (NASDAQ: NATI) with a Hold rating and $40 target, saying that shares could suffer if PMI decelerates in 3Q07 or negatively inflects in 1Q08.
  • Ametek (NYSE: AME) is is CIBC's top pick in the mid-cap Industrial Diversified area, due to the company's attractive asset portfolio and growth opportunities. CIBC initiated Ametek with a Sector Outperformer rating and $45 target...
OTHER INITIATIONS:
  • Ferris Baker Watts initiated DirecTV (NYSE: DTV) with a Buy rating and $29.50 target.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst initiations 6-28-07: AZN, DUK, JMP and SPR

MOST NOTEWORTHY: AstraZeneca (AZN), Ametek (AME), InterNAP Network Services (INAP) and Rosetta Genomics (ROSG) were today's noteworthy initiations:
  • Cowen believes AstraZeneca (NYSE: AZN) faces challenges from patent expirations, patent challenges, high-risk pipeline and value creation from deals, and initiated shares with a Neutral rating.
  • Ametek (NYSE: AME) was initiated at Friedman Billings with an Outperform rating and $44 target, as the firm believes AME has turned into a collection of niche-oriented high-value-added manufacturers of precision instrumentation, resulting in a high-margin, high-return business with above average growth.
  • InterNAP (NASDAQ: INAP) was initiated at Thomas Weisel with an Overweight rating, as the firm is positive on INAP's unique service offerings, VitalSteam acquisition opportunities, high growth customers, and improving collocation and bandwidth demand fundamentals.
  • Cantor expects Rosetta Genomics (NASDAQ: ROSG) to launch the world's first microRNA-based cancer diagnostic in the second-half of 2008 with a market of $200 million, and initiated shares with a Buy rating and $15 target.
OTHER INITIATIONS:
  • Duke Energy (NYSE: DUK) was initiated with a Market Perform rating at BMO Capital.
  • Merrill Lynch initiated shares of JMP Group (NYSE: JMP) with a Buy rating.
  • UBS initiated shares of Itron (NASDAQ: ITRI) with a Neutral rating and $82 target.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA-93.7910,197.47
NASDAQ-17.882,149.02
S&P 500-11.271,087.24

Last updated: November 12, 2009: 07:45 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance